en
E-mail us
(925) 558-5040
bd_global@crystalpharmatech.com
 cn
cn

Discovery & Development US 2025

We're heading to San Diego October 2-3 and bringing a team ready to talk First-Time-Right CMC for small molecules—from solid form to formulation and IND.


Meet Our Experts

Attendee: 

  • Alex Chen, Ph.D.

    Co-founder & CEO 

    Crystal Pharmatech

  • Beth Negash

    Business Development Director

    Candoo Pharmatech

  • Kevin Berkley

    Business Development Manager

    Crystal Pharmatech

Event Details

Date: October 2-3, 2025

Location: Sheraton San Diego Resort, San Diego, CA

Booth: 48


Presentation / Poster
Presentation

From Discovery to IND: Solid State and Formulation Strategies for Clinical Success

Date: October 2-3, 2025
Location: Sheraton San Diego Resort
Poster

Meeting Clinical Needs: Fast Onset Formulation Development for a CNS Drug

Date: October 2-3, 2025
Location: Sheraton San Diego Resort
Schedule a Meeting
Related Resources
Brise Pharma Presents“Best Partner”Trophy to Crystal Formulation Services, Recognizing Their Excellence in Drug Product CDMO Services
News
Brise Pharma Presents“Best Partner”Trophy to Crystal Formulation Services, Recognizing Their Excellence in Drug Product CDMO Services
04 Dec 2025
Crystal Pharmatech Receives CNAS Reaccreditation, Scope Expansion, and Address Approval
News
Crystal Pharmatech Receives CNAS Reaccreditation, Scope Expansion, and Address Approval
11 Aug 2025
Crystal Pharmatech and Divamics Announce Strategic Collaboration to Accelerate Drug Development through AI, Crystal Form, and Formulation Innovation
News
Crystal Pharmatech and Divamics Announce Strategic Collaboration to Accelerate Drug Development through AI, Crystal Form, and Formulation Innovation
09 May 2025
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics CMC Analytical Services Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Technology
Solid Form Screening Solid Form Developability Evaluation Absolute Structure Determination Crystallization Process Development Conventional Oral Solid Dosage Forms Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides Mini-tablet
Quick Links
Highlights News Events Knowledge Hub Webinar Series
Contact Us
bd_global@crystalpharmatech.com (925) 558-5040
U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512
2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512
CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123

Subscribe to be the first to get the updates!

Subscribe to be the first to get the updates!
Privacy Policy
Sitemap
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics CMC Analytical Services Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Technology
Quick Links
About Us Events
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512
2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512
CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
bd_global@crystalpharmatech.com (925) 558-5040
Privacy Policy
Sitemap